Lexaria Bioscience Corp. (LEXX)
2.88
-0.21
(-6.80%)
USD |
NASDAQ |
Oct 02, 16:00
2.77
-0.11
(-3.82%)
After-Hours: 20:00
Lexaria Bioscience Cash from Operations (TTM) : -7.426M for May 31, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | -7.426M |
| February 28, 2026 | -9.374M |
| November 30, 2025 | -8.708M |
| August 31, 2025 | -10.45M |
| May 31, 2025 | -9.700M |
| February 28, 2025 | -7.382M |
| November 30, 2024 | -6.503M |
| August 31, 2024 | -4.959M |
| May 31, 2024 | |
| February 29, 2024 | |
| November 30, 2023 | |
| August 31, 2023 | |
| May 31, 2023 | -5.436M |
| February 28, 2023 | -4.909M |
| November 30, 2022 | -4.958M |
| August 31, 2022 | -4.879M |
| May 31, 2022 | -4.782M |
| February 28, 2022 | -4.690M |
| November 30, 2021 | -4.338M |
| August 31, 2021 | -3.990M |
| May 31, 2021 | -3.550M |
| February 28, 2021 | -3.053M |
| November 30, 2020 | -2.882M |
| August 31, 2020 | -2.619M |
| May 31, 2020 | -2.756M |
| Date | Value |
|---|---|
| February 29, 2020 | -3.187M |
| November 30, 2019 | -3.037M |
| August 31, 2019 | -3.046M |
| May 31, 2019 | -3.105M |
| February 28, 2019 | -2.567M |
| November 30, 2018 | -2.545M |
| August 31, 2018 | -2.483M |
| May 31, 2018 | -1.762M |
| February 28, 2018 | -1.802M |
| November 30, 2017 | -1.709M |
| August 31, 2017 | -1.307M |
| May 31, 2017 | -1.453M |
| February 28, 2017 | -0.9582M |
| November 30, 2016 | -0.5529M |
| August 31, 2016 | -0.6609M |
| May 31, 2016 | -0.981M |
| February 29, 2016 | -1.259M |
| November 30, 2015 | -1.537M |
| August 31, 2015 | -1.501M |
| May 31, 2015 | |
| February 28, 2015 | |
| November 30, 2014 | |
| October 31, 2014 | |
| July 31, 2014 | -0.3374M |
| April 30, 2014 | -0.0543M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Target Group, Inc. (Canada) | -1.073M |
| InMed Pharmaceuticals, Inc. | -8.628M |
| XORTX Therapeutics, Inc. | -5.062M |
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -60.75M |